Company intelligence / Profile preview

Verso Biosciences

Ownership: Private
Development stage: Other

Overview

Verso Biosciences develops technology solutions to streamline data integration, simplify analysis/interpretation, and accelerate discovery in the life sciences. Their flagship product is MarkerLab®, a web-based platform enabling high-quality standardized multiomics data management and collaboration. The company partners with initiatives like the Periodic Table of Food Initiative to build public databases on food composition/functionality. No clinical results as they do not develop therapeutics or diagnostics directly.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Periodic Table of Food Initiative

Beyond the preview

Go deeper on Verso Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Verso Biosciences.

Explore the full profile